COLLATERAL RESISTANCE TO PHOTON AND NEUTRON-IRRADIATION IS ASSOCIATED WITH ACQUIRED CISPLATINUM RESISTANCE IN HUMAN OVARIAN TUMOR-CELLS

被引:15
作者
BRITTEN, RA
PEACOCK, J
WARENIUS, HM
机构
[1] UNIV LIVERPOOL,DEPT MED,CRC ONCOL RES UNIT,POB 147,LIVERPOOL L69 3BX,ENGLAND
[2] ROYAL MARSDEN HOSP,INST CANC RES,ACAD RADIOTHERAPY UNIT,SUTTON SM2 5PT,SURREY,ENGLAND
关键词
HUMAN CELL LINES; COLLATERAL RESISTANCE; CISPLATINUM; PHOTONS; NEUTRONS;
D O I
10.1016/0167-8140(92)90327-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The melphalan resistant variant of the human ovarian OAW42 tumour cell line has previously been shown to be collaterally resistant to photon irradiation, but not to fast neutrons [4]. In the present study, the "in vitro" photon and neutron radiosensitivity of human ovarian OAW42 tumour cells with acquired resistance to cis-platinum has been studied, to determine whether a similar pattern of cross-resistance exists between cis-platinum and these ionising radiations. Analysis of SF2 values suggests that resistance to cis-platinum conferred a 3-fold decrease in sensitivity to photons, primarily attributable to a 5-fold decrease in the magnitude of the initial slope (alpha). Depletion of GSH by BSO restored the magnitude of alpha to a value similar to that of the parental line. However, cis-platinum resistant OAW42/CP cells, in contrast to melphalan resistant cells, were 1.5-fold more resistant to "fast" neutrons (assessed at D0.1 survival level) than the parental OAW42 cell line. The mechanism for the collateral resistance between cis-platinum, and both photons and neutrons remains to be determined, but although GSH levels may be directly, or indirectly involved in the collateral resistance to photons, they would appear not to involved with the mechanisms responsible for collateral neutron resistance, in the cis-platinum resistant human ovarian cell lines used in this study.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 30 条
[1]  
Alper T, 1979, CELLULAR RADIOBIOLOG
[2]  
ANDREWS PA, 1987, CANCER CHEMOTH PHARM, V19, P149
[3]   THE CLATTERBRIDGE HIGH-ENERGY NEUTRON THERAPY FACILITY - SPECIFICATION AND PERFORMANCE [J].
BONNETT, DE ;
BLAKE, SW ;
SHAW, JE ;
BEWLEY, DK .
BRITISH JOURNAL OF RADIOLOGY, 1988, 61 (721) :38-46
[4]   MELPHALAN RESISTANT HUMAN OVARIAN TUMOR-CELLS ARE CROSS-RESISTANT TO PHOTONS, BUT NOT TO HIGH LET NEUTRONS [J].
BRITTEN, RA ;
WARENIUS, HM ;
WHITE, R ;
BROWNING, PGW ;
GREEN, JA .
RADIOTHERAPY AND ONCOLOGY, 1990, 18 (04) :357-363
[5]  
BRITTEN RA, 1992, IN PRESS INT J RAD O
[6]   THE RADIORESPONSIVENESS OF HUMAN-TUMORS AND THE INITIAL SLOPE OF THE CELL-SURVIVAL CURVE [J].
DEACON, J ;
PECKHAM, MJ ;
STEEL, GG .
RADIOTHERAPY AND ONCOLOGY, 1984, 2 (04) :317-323
[7]   FLUORESCEIN ISOTHIOCYANATE STAINING INTENSITY AS A PROBE OF HYPERTHERMIA-INDUCED CHANGES IN CHROMATIN CONFORMATION [J].
DYSON, JED ;
BRITTEN, RA ;
BATTERSBY, I ;
SURREY, CR .
CYTOMETRY, 1989, 10 (02) :174-184
[8]  
ENSLEY JF, 1984, CANCER, V54, P811, DOI 10.1002/1097-0142(19840901)54:5<811::AID-CNCR2820540508>3.0.CO
[9]  
2-E
[10]   INHERENT CELLULAR RADIOSENSITIVITY AS A BASIC CONCEPT FOR HUMAN-TUMOR RADIOTHERAPY [J].
FERTIL, B ;
MALAISE, EP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (05) :621-629